SRPL2023-10-012023-12-31 SRPL2023-10-012023-12-31 SRPL2023-10-012023-12-31in-bse-fin:OneOperatingExpenses01Member SRPL2023-10-012023-12-31in-bse-fin:FourOperatingExpenses01Member SRPL2023-12-31 iso4217:INRxbrli:purexbrli:sharesiso4217:INRxbrli:shares SRPL NOTLISTED Shree Ram Proteins Limited Equity 2023-04-01 2024-03-31 2024-05-06 2024-04-16 INR Lakhs Third quarter 17:30:00 18:30:00 2024-05-06 2024-05-06 Not applicable Single segment SOLVENT PRODUCT 2023-10-01 2023-12-31 Unaudited Standalone 0.00 0.00 0.00 65491000.00 0.00 -29942000.00 1175000.00 68000.00 2054000.00 8767000.00 47613000.00 -47613000.00 0.00 -47613000.00 0.00 -1823000.00 -1823000.00 0.00 -45790000.00 0.00 0.00 0.00 0.00 -45790000.00 -8000.00 -45798000.00 0.00 0.00 214200000.00 1 -0.21 -0.21 0.00 0.00 -0.21 -0.21 0.00 0.00 0.00 1. The Company's financial results for the quarter ended December 31, 2023 have been reviewed by the Audit Committee and subsequently approved & taken on record by the Board of Directors of the Company at its meeting held on 06th May, 2024. 2. The Unaudited financial results for the quarter ended December 31, 2023 have been prepared in accordance with the recognition and measurement principles laid down in the Indian Accounting Standards 34 Interim Financial Reporting ( Ind AS 34 ) prescribed under section 133 of The Companies Act , 2013 and other recognised accounting practices and the policies to the extend applicable. 3. Figures of previous reporting periods have been regrouped/reclassified wherever necessary to correspond with the figures of the current reporting period. 4. The Company's Operations fall under a single segment Solvent Products . Hence, Segment reporting is not applicable as per Indian Accounting Standard (Ind AS) 108- Segment Reporting. 5. During the year, the Company on 19 May 2023 ( Record Date ) ,sub-divided/split of existing Equity Shares of the Company from I(One) Equity Share having face value of Rs.10/ -(Rupees Ten Only) each fully paid up, into 10 (Ten) Equity Share of the face value of Rs. l/- (One) each fully paid up. Accordingly, earnings per share of comparative periods presented has been calculated based on number of shares outstanding in respective periods, as increased by sub-divided/split of shares. 6. The Company has defaulted in the repayment of its loans as well as the payment of its statutory dues in the period under review. The Company has withdrawn its Rights Issue on [25/08/2023] due to lack of investor interest. The Company is exploring all avenues to mitigate the current circumstances. 7. The Corporate Insolvency Resolution Process(CIRP) proceeding has been initiated against the Company by NCLT, ahmedabad bench with effect from 11.01.2023 under the provision of The Insolvency and Bankruptcy Code, 2016 for non payment of amount to one of the company's creditor. However, stay has been granted by National Company law Appellate Tribunal Principal Bench, New Delhi, as on 25.01.2023 against above proceeding and ordered to pay amount of Rs. 1,21,82,419 / -within two weeks of the order in the name of The Pay and accounts officer, Ministry of corporate affairs, New Delhi . Single segment 2023-04-01 2023-12-31 Unaudited Standalone 147660000.00 3292000.00 150952000.00 168242000.00 0.00 945000.00 4873000.00 14273000.00 6161000.00 22730000.00 217224000.00 -66272000.00 0.00 -66272000.00 0.00 -3615000.00 -3615000.00 0.00 -62657000.00 0.00 0.00 0.00 0.00 -62657000.00 -25000.00 -62682000.00 0.00 0.00 214200000.00 1 -0.29 -0.29 0.00 0.00 -0.29 -0.29 0.00 0.00 0.00 Other Expenses 8767000.00 Other Expenses 22730000.00 -11000.00 -33000.00 -3000.00 -8000.00 0.00 0.00